Human IgG1 (LALAPG) kappa-Deruxtecan, ADC Control is an IgG1-based antibody-drug conjugate control containing Deruxtecan (DXd) with Fc LALAPG modification. It can be used as a control in ADC.
* VAT and and shipping costs not included. Errors and price changes excepted